Currently, hepatitis C treatment in Australia involves two different regimes. People with HCV genotype 1 are offered a combination of three drugs: pegylated interferon injections, ribavirin pills and boceprevir pills. People with genotypes 2 & 3 are offered a combination of two drugs: pegylated interferon injections and ribavirin pills. These regimes are given for up to 48 weeks and provide a cure rate of around 80%. The double combination treatment is available to most people on a subsidised basis through Medicare. The triple combination treatment is not yet subsidised through Medicare. People with genotype 1 who can't afford triple treatment are offered double combination treatment which gives a cure rate of 50%. In all cases, treatment often involves significant side effects and people need to find out about this aspect of treatment before deciding whether or not to go on treatment.
You must be a HealthShare member to report this post.
to your account or now (it's free).